Katia Collomp | Health Sciences | Women Researcher Award

Posted on by Forensic Scientist

Prof. Dr. Katia Collomp | Health Sciences | Women Researcher Award

Professor, Orleans University | France

Professor Catherine (Katia) Collomp is a distinguished academic in Sport Sciences at the University of Orleans, France, and a Research Fellow at the French Antidoping Laboratory (LADF), University of Paris-Saclay. With an exceptional career dedicated to the intersection of pharmacology, exercise physiology, and anti-doping science, she is also a key member of the CIAMS laboratory. Her work has significantly influenced anti-doping policies and research ethics in sports science, making her a leading voice in the field.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Experience & Leadership
    Professor Collomp has over three decades of continuous and impactful contributions to sport sciences, pharmacology, and anti-doping research. Her role as a full professor and long-term research fellow at the French Antidoping Laboratory (LADF) demonstrates academic excellence and institutional commitment.

  • Interdisciplinary Expertise
    Her background as a pharmacist and researcher in physical activity and health sciences reflects a rare interdisciplinary blend that strengthens both the scientific rigor and practical impact of her work, especially in anti-doping studies—a field requiring deep knowledge of pharmacology, ethics, and sports physiology.

  • Global and National Collaborations
    Her postdoctoral research in Canada and continued collaborations with major institutions like University of Paris-Saclay and WADA position her as an internationally connected researcher. These connections indicate a high level of respect and trust in her expertise.

  • Institutional Service & Policy Impact
    Professor Collomp has held numerous leadership and advisory roles:

    • Co-director of the CIAMS lab team

    • Expert reviewer for HCERES

    • Member of ethics committees and national academic councils (CNU

🎓 Education

Katia Collomp began her academic journey by earning her degree in Pharmacy from the University of Montpellier I in 1987. She went on to complete her Ph.D. in 1991, focusing on “Physical activity, psychological and motor development” within the Life Sciences and Health section at the same university. 📘 Following her doctorate, she undertook a postdoctoral fellowship from 1992 to 1993 at the INRS Santé Antidoping Laboratory in Montréal, deepening her expertise in doping control and bioanalysis. She achieved her Habilitation à Diriger des Recherches (HDR) in 1997, establishing her as a senior scientific leader in her field.

💼 Experience

From 1993 to 1997, Katia served as a Pharmacist at the Mission Sports Medicine – Doping Control, Ministry of Sports in Paris, contributing to the foundation of anti-doping protocols. In 1997, she joined the French Antidoping Laboratory (LADF) as a Research Fellow, a position she continues to hold. Her academic path includes positions as Associate Professor (1997–2001) at the University of Paris XI and Full Professor (2001–present) at the University of Orleans. She has led multiple research teams and contributed to national committees on education and ethics.

🔬 Research Interest On Health Sciences

Her research interests span pharmacology, performance-enhancing substances, glucocorticoids, sports physiology, and rehabilitation. She focuses on the effects of physical activity on health and doping control, contributing to ethical frameworks and scientific methodologies that guide international sports policies. Her work helps shape understanding of how substances influence athletic performance and rehabilitation, playing a crucial role in global anti-doping efforts.

🏅 Awards & Honors

Professor Collomp has served in multiple national and international scientific committees, including as an expert for HCERES, a member of the WADA Glucocorticoids Threshold Working Group, and the Research Ethics Committee of Paris-Saclay (CER). She is currently a member of the French “Conseil National des Universités” (CNU 74), reflecting her respected status in the academic and sports science community. 🎖️ Her leadership and advocacy for scientific integrity in sports continue to influence generations of researchers and athletes alike.

📚 Publications

1. Hormonal and Metabolic Responses Across Phases of Combined Oral Contraceptive Use and Menstrual Cycle in Young Elite Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Caroline Teulier, Juliette Bonnigal, Nathalie Crépin, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: European Journal of Applied Physiology

  • DOI: 10.1007/s00421-025-05745-x

2. Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

  • Authors: Katia Collomp, Caroline Teulier, Carole Castanier, Juliette Bonnigal, Alexandre Marchand, Corinne Buisson, Magnus Ericsson, Nathalie Crépin, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2025

  • Journal: Drug Testing and Analysis

  • DOI: 10.1002/dta.3859

3. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: The Journal of Sports Medicine and Physical Fitness

  • DOI: 10.23736/s0022-4707.24.16488-2

4. Editorial: Women in Sports 2022

  • Authors: Katia Collomp, S. Lorenzetti

  • Year: 2024

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2024.1367605

5. Physical Activity and Female Students’ Perception of Menstrual Symptoms: Impact of Hormonal Contraception

  • Authors: Katia Collomp, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Valérie Bougault

  • Year: 2024

  • Conference Paper: HAL: hal-04936867

  • Citations: 0​

6. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Caroline Teulier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2024

  • Conference Paper: HAL: hal-04936872

7. Physical Activity and Combined Hormonal Contraception: Association with Female Students’ Perception of Menstrual Symptoms

  • Authors: Valérie Bougault, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2023.1185343

8. Short-Term Effect of Bariatric Surgery on Cardiorespiratory Response at Submaximal, Ventilatory Threshold, and Maximal Exercise in Women with Severe Obesity

  • Authors: Nancy Vibarel-Rebot, Marine Asselin, Virgile Amiot, Katia Collomp

  • Year: 2023

  • Journal: Obesity Surgery

  • DOI: 10.1007/s11695-023-06550-1

9. Summer Olympic Sports and Female Athletes: Comparison of Anti-Doping Collections and Prohibited Substances Detected in Australia and New Zealand vs. France

  • Authors: Corinne Buisson, L. Brooker, C. Goebel, R. Morrow, R. Chakrabarty, N. Speers, A. Molina, Magnus Ericsson, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2023.1213735

10. Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences

  • Authors: Katia Collomp, Magnus Ericsson, N. Bernier, Corinne Buisson

  • Year: 2022

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2022.839976

🔚 Conclusion

Professor Catherine Collomp exemplifies the union of scientific excellence, ethical integrity, and academic leadership in the field of sport sciences and pharmacology. Her dedication to clean sport, athlete health, and rigorous scientific inquiry continues to guide anti-doping practices across the globe. Her nomination for any award would reflect her lifelong commitment to advancing science in service of both health and fairness in athletics.

Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Posted on by Forensic Scientist

Dr. Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Epidemiologist | Pfizer UK Ltd | United Kingdom

Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.

Profile

Scopus

Strengths for the Awards

  • Prolific Research Contributions:
    • Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
    • Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
  • Impact on Public Health:
    • His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
  • Industry and Academic Experience:
    • A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
    • This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.

Education 🎓

Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.

Professional Experience 💼

  • Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
  • Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
  • May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.

Research Interests On Medicine 🧬

Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.

Awards and Recognition 🏆

Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.

Publications 🔖

1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus

  • Authors: Vyse, A., Wright, H., Begier, E.
  • Year: 2024
  • Citations: 0

2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data

  • Authors: Vyse, A., Colby, E.
  • Year: 2024
  • Citations: 0

3. Incidence of symptomatic Lyme borreliosis in nine European countries

  • Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
  • Year: 2024
  • Citations: 1

4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment

  • Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
  • Year: 2024
  • Citations: 0

5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom

  • Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
  • Year: 2023
  • Citations: 9

6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK

  • Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
  • Year: 2023
  • Citations: 0

7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  • Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
  • Year: 2023
  • Citations: 4

8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019

  • Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 5

9. Incidence of Lyme Borreliosis in Germany

  • Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 2

10. Incidence of Lyme Borreliosis in the Dutch General Practice Population

  • Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
  • Year: 2023
  • Citations: 3

Conclusion 🌐

Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.